Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study links GLP-1 treatment to fewer alcohol drinking days

13

Jul 2026

Study links GLP-1 treatment to fewer alcohol drinking days

Current GLP-1 receptor agonist prescriptions were associated with modestly lower AUDIT-C scores in a large, diverse US cohort. The difference appeared to reflect less frequent drinking rather than fewer drinks per occasion or fewer binge-drinking episodes.

Gum disease bacteria linked to calcific aortic valve stenosis

12

Jul 2026

Gum disease bacteria linked to calcific aortic valve stenosis

Gum disease bacteria may spur calcium buildup in the heart's aortic valve, leading to a common and serious heart valve disease, according to preliminary, independent research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026.

Global study reveals country-specific patterns in dementia risk factors

12

Jul 2026

Global study reveals country-specific patterns in dementia risk factors

A major, USC-led study of more than 214,000 older adults across 14 countries and regions finds that the most common controllable risk factors for dementia - such as low education, high blood pressure and smoking - vary widely from country to country, meaning a one-size-fits-all approach to prevention won't work everywhere.

New benchmark shows AI still misses the human side of mental health care

12

Jul 2026

New benchmark shows AI still misses the human side of mental health care

PsyEval is a new benchmark that tests how large language models perform on mental health knowledge, diagnostic assessment, and emotional support tasks. The study found that leading models can show strong factual recall and fluent responses, but still struggle with empathy, clinical nuance, prompt sensitivity, and safe diagnostic behavior.

Cold-exposed mothers pass metabolic protection to male rat offspring through milk

12

Jul 2026

Cold-exposed mothers pass metabolic protection to male rat offspring through milk

Maternal cold exposure during early pregnancy improved glucose control and reduced liver fat in male rat offspring, with benefits persisting into late adulthood. The findings implicate a breast milk LCA, gut microbiota, and Th17 immune pathway, while human cohort data showed an observational link between winter conception and lower MASLD risk.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.